Research analysts at William Blair decreased their FY2025 earnings per share (EPS) estimates for shares of AbbVie in a note ...

Analysts at William Blair upped their FY2024 earnings per share (EPS) estimates for shares of Cheesecake Factory in a ...

William Blair has recently initiated Vigil Neuroscience Inc (VIGL) stock to Outperform rating, as announced on December 4, 2024, according to Finviz. Earlier, on December 19, 2023, Morgan Stanley had ...

Parsons (NYSE:PSN) on Thursday was downgraded to Market Perform from a previous investment rating of Outperform by analysts at financial-services firm William Blair. They said the defense, ...

William Blair has recently reduced Applied Therapeutics Inc (APLT) stock to Mkt Perform rating, as announced on December 23, 2024, according to Finviz. Earlier, on December 2, 2024, UBS had reduced ...

William Blair downgraded Charles River (CRL) to Market Perform from Outperform without a price target “There is simply too much working against Charles River in the near term to make the stock ...

Stephanie Braming, global head of investment management at William Blair, plans to retire in the fourth quarter, a news release said. She joined the Chicago-based firm in 2004 as a portfolio manager ...

William Blair analysts downgraded shares of Charles River Laboratories International Inc. (NYSE:CRL) stock from Outperform to ...

Vigil Neuroscience's VG-3927 Phase 1 trial shows strong safety, 50% sTREM2 reduction, and potential Alzheimer's treatment; Phase 2 begins Q3 2025.

Vertical Aerospace (Vertical) (NYSE: EVTL) ("Vertical" or the "Company"), a global aerospace and technology company that is ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...